Kyle Bass, a US hedge fund manager, is taking legal action against the US pharmaceutical industry. He plans on challenging drug patents of 15 companies that have a combined market cap of $450 billion. The founder of Hayman Capital claims that companies expand their patents by just changing the dosage or packaging. Part of an investment strategy, the legal challenge is likely to result in a fall of medicine prices in the US.
Photo Feature
Patent fight
A US hedge fund manager, is taking legal recourse to challenge drug patents of 15 companies
Editor's Pick
Most Popular
Summer wine and salad
Kishore Singh - January 19, 2015
A double topping for growth
Meghna Maiti - January 15, 2015
Scriptures for success
Kripa Mahalingam - January 27, 2015
Decoupage goes digital
Kishore Singh - January 27, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021